Rabindra Tirouvanziam, PhD, a researcher at the Stanford University School of Medicine, has found immune cells play a surprisingly active role in damaging the lungs of cystic fibrosis patients. His discovery could lead to new treatments for the genetic disease. The research, which will be published online March 23 in the Proceedings of the National Academy of Sciences, opens up new targets for cystic fibrosis treatment, Tirouvanziam said. Tirouvanziam collaborates with the clinical and research team at the CF Center at Stanford, located at Lucile Packard Children's Hospital at Stanford.
Link to this comment:
All Comments (0)